CLDX
NASDAQ · Biotechnology
Celldex Therapeutics Inc
$29.04
-1.06 (-3.52%)
Open$30.10
Previous Close$30.10
Day High$30.17
Day Low$28.61
52W High$45.14
52W Low$22.10
Volume—
Avg Volume797.8K
Market Cap2.35B
P/E Ratio—
EPS$-4.36
SectorBiotechnology
Analyst Ratings
Strong Buy
21 analysts
Price Target
+79.3% upside
Current
$29.04
$29.04
Target
$52.08
$52.08
$39.61
$52.08 avg
$81.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.89M | 2.17M | 613.37M |
| Net Income | -315,514,071 | -327,032,896 | -4,777,656 |
| Profit Margin | -16,748.0% | -15,910.6% | -0.8% |
| EBITDA | -346,274,202 | -378,855,800 | -9,452,277 |
| Free Cash Flow | — | — | -4,482,621 |
| Rev Growth | -13.2% | -13.2% | +23.6% |
| Debt/Equity | — | — | 0.95 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |